Urothelial Carcinoma

• CLINICAL_TRIALS trial_result · 2014-09-19
  Clinical Trial Update: Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer [Phase 2]

  Phase 2 trial of ABI-007 (nab-paclitaxel) combined with carboplatin and gemcitabine as first-line therapy for advanced urothelial cancer; th…

• CLINICAL_TRIALS trial_result · 2010-03-02
  Clinical Trial Update: Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium [Phase 2]

  Phase 2 trial evaluating vinflunine in locally advanced or metastatic urothelial carcinoma of the urothelium (bladder cancer); the study has…

• CLINICAL_TRIALS trial_result · 2010-01-07
  Clinical Trial Update: Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract [Phase 3]

  Phase III trial evaluating vinflunine plus best supportive care versus best supportive care alone in patients with urothelial tract transiti…

• CLINICAL_TRIALS trial_result · 2009-06-04
  Clinical Trial Update: Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the Urothelium [Phase 2]

  Phase 2 trial evaluating S-8184 for locally advanced, metastatic, or recurrent urothelial carcinoma (transitional cell carcinoma of the urot…

• CLINICAL_TRIALS trial_result · 2009-06-04
  Clinical Trial Update: TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium [Phase 2]

  Phase 2 trial of TOCOSOL Paclitaxel for metastatic or locally advanced unresectable transitional cell carcinoma of the urothelium has comple…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2007-11-06
  Clinical Trial Update: 2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen [Phase 2]

  Phase 2 trial completed evaluating gemcitabine monotherapy as second-line treatment for urothelial carcinoma after cisplatin-based therapy.

• CLINICAL_TRIALS trial_result · 2006-07-19
  Clinical Trial Update: A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium [Phase 2]

  This update describes the completed Phase 2 trial of pemetrexed (ALIMTA) in locally advanced or metastatic urothelial carcinoma.

• CLINICAL_TRIALS trial_result · 2006-07-19
  Clinical Trial Update: A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium [Phase 2]

  A Phase 2 study evaluated ALIMTA (pemetrexed) plus gemcitabine in locally advanced or metastatic urothelial carcinoma and has completed the …